ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
145.31
+6.96 (5.03%)
At close: Dec 24, 2025, 1:00 PM EST
147.25
+1.94 (1.34%)
After-hours: Dec 24, 2025, 4:59 PM EST
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
$90,310
Profits / Employee
-$4,991,098
Market Cap
11.18B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 69 | 8 | 13.11% |
| Dec 31, 2023 | 61 | 37 | 154.17% |
| Dec 31, 2022 | 24 | 0 | - |
| Dec 31, 2021 | 24 | -3 | -11.11% |
| Dec 31, 2020 | 27 | 1 | 3.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ABVX News
- 2 days ago - Abivax: Here's Why Eli Lilly Could Want Its Oral Ulcerative Colitis Therapy - Seeking Alpha
- 6 days ago - Abivax to be Added to Nasdaq Biotechnology Index - GlobeNewsWire
- 7 days ago - Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings - GlobeNewsWire
- 13 days ago - Abivax: "Strong Buy" On Obefazimod New UC Data And Maintenance Results Coming Q2 2026 - Seeking Alpha
- 15 days ago - What's Happening With French Biotech Abivax Stock On Wednesday? - Benzinga
- 15 days ago - French biotech Abivax's shares climb on Eli Lilly bid rumors - Reuters
- 5 weeks ago - 6 Healthcare Stocks With Strong Upward Momentum - Benzinga
- 6 weeks ago - Abivax: Phase 3 Data Was A Home Run, Top Target For M&A In 2026 - Seeking Alpha